“Burgeoning advances in precision medicine and allied technologies are rapidly changing the practice of medicine yet the most profound opportunities to transform health care are yet to come. New capabilities and challenges require the convergence of thinking from the community and stakeholders. PMWC Duke is designed to be a step in that direction. Attendees from broad areas of precision medicine will convene to explore the latest in advances and challenges facing clinical adoption of these approaches.”

The PMWC 2018 Duke Program Committee:

“Burgeoning advances in precision medicine and allied technologies are rapidly changing the practice of medicine yet the most profound opportunities to transform health care are yet to come. New capabilities and challenges require the convergence of thinking from the community and stakeholders. PMWC Duke is designed to be a step in that direction. Attendees from broad areas of precision medicine will convene to explore the latest in advances and challenges facing clinical adoption of these approaches.”

The PMWC 2018 Duke Program Committee:

Ralph Snyderman Chancellor Emeritus, Duke University

Geoffrey Ginsburg Prof. of Medicine, Duke University School of Medicine

Tal Behar Co-Founder & President, PMWC

Robert M. Califf Vice Chancellor Duke University, School of Medicine

Ken Tindall Senior VP, North Carolina Biotech Center

 

PMWC 2018 Duke at the Washington Duke Inn will focus on success factors of varied technologies in precision medicine, how these innovations have and will continue to impact medicine, the challenges we still need to overcome to bring them to the clinic, the evidence necessary to encourage wider adoption by health care providers, elements needed to satisfy payors and regulators, and last but not least, why engagement with the community is critical for ultimate success and the approach we should take to achieve it.

PMWC 2018 Duke has been structured to focus on exactly these objectives and includes the following sessions and panel discussions:

• Efforts to Accelerate Precision Medicine with Lauren Silvis, (Chief of Staff, FDA) and Patrick Conway (BCBSNC)
• The recent insights from the All of Us Research Program with Stephanie Devaney (NIH)
• Recent Advancements and new applications in AI and Machine Learning with Larry Carin (Duke), Guido Lanza (Numerate) and Michael Pencina (Duke)
• Why we can’t ignore the Microbiome anymore with Jeff Gordon (Washington University), Lawrence David (Duke), and Rita Colwell (Johns Hopkins)
• New Emerging Technologies in Precision Medicine and their clinical impact with Mickey Kertesz (Karius Dx), Bob Langer (MIT), and Dawn Barry (Luna DNA)
• Where we stand with understanding Resilience with Stephen Friend (Sage Bionetworks) and Cathleen Colon-Emeric (Duke)
• Why we need Diversity in Precision Medicine with Hannah Valantine (NIH)
• A panel discussion around the Investment Perspective in Precision Medicine with Mike Pellini (Section 32) and Arthur Pappas (Pappas Capital)
• The latest about Point of Care Dx Platforms with Thierry Bernard (Qiagen), Richard Zane (University of Colorado), and Brian Caveney (Labcorp)
• A Panel on the Precision Medicine Workforce with Jeffrey Balser (Vanderbilt University Medical Center), Catherine Lucey (UCSF) and Susanne Haga (Duke)
• How Large Scale Bio-Data Resources Support Drug Development with Aris Baras (Regeneron)
• Approaches towards Understanding and Enhancing Human Longevity with Tom Caskey (Baylor College of Medicine)
• And updates on:
  • Precision Public Health with Debra Duquette (Northwestern) and Ebony Boulware (Duke)
  • The Implementation into Healthcare Delivery with Geoff Ginsburg (Duke)
  • Gene Editing with Bill Lundberg (CRISPR Therapeutics), Charles Gersbach (Duke), Edward Conner (Sangamo Therapeutics) and Derek Jantz (Precision BioSciences)
  • Immunotherapy with Nic Dracopoli (PGDx) and Mark Miglarese (Caris Life Sciences)
  • Rare Disease Diagnosis with Vandana Shashi (Duke)
  • The Baseline Project with Robert Califf (Duke)
  • Neoantigens with Ben Vincent (UNC)
  • Robust Clinical Decision Support Tools (IBM)
  • Pharmacogenomics with Bill Evans and Mary Relling (both at St. Jude Children’s Hospital)
  • Digital Phenotyping with Eric Perakslis (Datavant)
• Awards Presentation: 2018 PMWC Luminary Award – Dr. Jeffrey Gordon, Distinguished Professor (Washington University)

Please join us and an exciting lineup of speakers for PMWC Duke Sept. 24-25 to help shape the next stage of precision medicine in the clinic!